User profiles for SN Ladhani
 | Shamez LadhaniImmunisation Department, Public Health England Verified email at phe.gov.uk Cited by 30715 |
[HTML][HTML] Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies
…, LL O'Mahoney, TJ Stephenson, SN Ladhani… - Journal of Infection, 2022 - Elsevier
Background Data on the long-term impact of SARS-CoV-2 infection in children and young
people (CYP) are conflicting. We assessed evidence on long-term post-COVID symptoms in …
people (CYP) are conflicting. We assessed evidence on long-term post-COVID symptoms in …
The changing and dynamic epidemiology of meningococcal disease
…, B Greenwood, LH Harrison, J Jelfs, SN Ladhani… - Vaccine, 2012 - Elsevier
The epidemiology of invasive meningococcal disease continues to change rapidly, even in
the three years since the first Meningococcal Exchange Meeting in 2008. Control of disease …
the three years since the first Meningococcal Exchange Meeting in 2008. Control of disease …
[HTML][HTML] The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination
…, A von Gottberg, R Borrow, ME Ramsay, SN Ladhani - Journal of Infection, 2020 - Elsevier
Neisseria meningitidis is a major cause of bacterial meningitis and septicaemia worldwide
and is associated with high case fatality rates and serious life-long complications among …
and is associated with high case fatality rates and serious life-long complications among …
[HTML][HTML] Duration of protection against mild and severe disease by Covid-19 vaccines
Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
the virus that causes coronavirus disease 2019 (Covid-19), have been used since …
the virus that causes coronavirus disease 2019 (Covid-19), have been used since …
[HTML][HTML] Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant
Background A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the
omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly …
omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly …
COVID-19 vaccination during pregnancy: coverage and safety
Background Concerns have been raised regarding a potential surge of COVID-19 in
pregnancy, secondary to the rising numbers of COVID-19 in the community, easing of societal …
pregnancy, secondary to the rising numbers of COVID-19 in the community, easing of societal …
[HTML][HTML] Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 …
…, P Krizova, A Kuch, SN Ladhani… - The Lancet Digital …, 2021 - thelancet.com
Background Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis,
which are typically transmitted via respiratory droplets, are leading causes of invasive …
which are typically transmitted via respiratory droplets, are leading causes of invasive …
[HTML][HTML] Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study
…, V Poustie, T Segal, K Sharma, SN Ladhani - The Lancet Child & …, 2022 - thelancet.com
Background We describe post-COVID symptomatology in a non-hospitalised, national sample
of adolescents aged 11–17 years with PCR-confirmed SARS-CoV-2 infection compared …
of adolescents aged 11–17 years with PCR-confirmed SARS-CoV-2 infection compared …
[HTML][HTML] Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an …
Background The 13-valent pneumococcal conjugate vaccine (PCV13) protects against key
serotypes that increased after routine immunisation with the seven-valent vaccine (PCV7), …
serotypes that increased after routine immunisation with the seven-valent vaccine (PCV7), …
Effectiveness of COVID-19 vaccines against the Omicron (B. 1.1. 529) variant of concern
Background A rapid increase in cases due to the SARS-CoV-2 Omicron (B.1.1.529) variant
in highly vaccinated populations has raised concerns about the effectiveness of current …
in highly vaccinated populations has raised concerns about the effectiveness of current …